KevinLouisRakszawskiMD
Hematology • Hershey, PAHematologic Oncology
Assistant Professor of Medicine, Vice Chair, Quality and Patient Safety - Division of Hematology/Oncology
Dr. Rakszawski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
500 University Dr
CH046
Hershey, PA 17033Phone+1 717-531-8678Fax+1 717-531-5111
Summary
- Dr. Kevin Rakszawski is a hematologic oncologist in Hershey, PA and is affiliated with Penn State Milton S. Hershey Medical Center and the Penn State Cancer Institute. He received his medical degree from Pennsylvania State University College of Medicine and has been in academic practice since 2019. He specializes in hematologic oncology and is experienced in multiple myeloma, lymphoma, stem cell transplantation, and CAR-T cell therapy. He has received numerous awards for teaching hematology/oncology and the medical humanities. In 2023 he was named Physician of the Year at Penn State Health Milton S. Hershey Medical Center. He was also named as one of the Top Physicians Under 40 by the Pennsylvania Medical Society. He also serves as Vice Chair of Quality and Patient Safety for the Penn State Cancer Institute.
Education & Training
Penn State Milton S Hershey Medical CenterFellowship, Hematology and Medical Oncology, 2016 - 2019- Penn State Milton S Hershey Medical CenterResidency, Internal Medicine, 2013 - 2016
Pennsylvania State University College of MedicineClass of 2013
Certifications & Licensure
PA State Medical License 2013 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Top Physicians Under 40 Pennsylvania Medical Society, 2022
- Physician of the Month (December) Penn State Health Miilton S. Hershey Medical Center, 2022
- Physician of the Year Penn State Health Milton S. Hershey Medical Center, 2022
Clinical Trials
- S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration Start of enrollment: 2019 Aug 13
- Testing the Addition of Ixazomib/Placebo to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial Start of enrollment: 2022 Feb 16
Publications & Presentations
PubMed
- 2 citationsDonor HLA mismatch promotes full donor T-cell chimerism in the allogeneic stem cell transplant with reduced-intensity conditioning and post-transplant cyclophosphamide...Joseph Cioccio, Kevin Rakszawski, Hong Zheng, Myles Nickolich, Seema Naik
Annals of Hematology. 2023-03-01 - 633 citationsAssociation of the Extent of Resection With Survival in Glioblastoma: A Systematic Review and Meta-analysis.Timothy J. Brown, Matthew Brennan, Michael Li, Ephraim W. Church, Nicholas J. Brandmeir
JAMA Oncology. 2016-11-01 - 39 citationsOutcomes in patients treated with chimeric antigen receptor T-cell therapy who were admitted to intensive care (CARTTAS): an international, multicentre, observational ...Elie Azoulay, Pedro Castro, Adel Maamar, Victoria Metaxa, Alice Gallo De Moraes
The Lancet. Haematology. 2021-05-01
Journal Articles
- Clofarabine Followed by Haploidentical Stem Cell Transplant Using Fludarabine, Busulfan, and Total-Body Irradiation with Post-Transplant Cyclophosphamide in Non-Remiss...Shin Mineishi, David Claxton, Kevin Rakszawski, Hiroko Shike, International Journal of Hematology
- Recent advances in pancreatic cancer: updates and insights from the 2015 annual meeting of the American Society of Clinical OncologyAbrams MJ, Rakszawski K, Vasekar M, Passero F, Abbas A, Jia Y, Saif MW., Therapeutic Advances in Gastroenterology, 3/2016
Press Mentions
How the COVID-19 Outbreak Is Affecting Healthcare for People with CancerMarch 22nd, 2020
Rare Cancer Linked with Textured Breast Implants May Be Underreported, MisunderstoodOctober 18th, 2017
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
